Which has stronger valuation & earnings, CCLD or XPER?

CareCloud has higher earnings, but lower revenue than Xperi. Xperi is trading at a lower price-to-earnings ratio than CareCloud, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio CareCloud $120.50M 0.83 $10.80M $0.11 21.50 Xperi $448.11M 0.84 -$56.34M -$0.99 N/A

Is CCLD or XPER more profitable?

CareCloud has a net margin of 7.87% compared to Xperi's net margin of -10.22%. CareCloud's return on equity of 24.05% beat Xperi's return on equity. Company Net Margins Return on Equity Return on Assets CareCloud 7.87% 24.05% 16.38% Xperi -10.22% 1.09% 0.73%

Is CCLD or BLND more profitable?

CareCloud has a net margin of 7.87% compared to Blend Labs' net margin of -3.72%. CareCloud's return on equity of 24.05% beat Blend Labs' return on equity. Company Net Margins Return on Equity Return on Assets CareCloud 7.87% 24.05% 16.38% Blend Labs -3.72% N/A -1.63%

Does the media refer more to CCLD or BLND?

In the previous week, CareCloud and CareCloud both had 3 articles in the media. CareCloud's average media sentiment score of 0.47 beat Blend Labs' score of -0.33 indicating that CareCloud is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment CareCloud 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Blend Labs 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Do analysts recommend CCLD or XNET?

CareCloud currently has a consensus price target of $3.25, indicating a potential upside of 37.42%. Given CareCloud's stronger consensus rating and higher possible upside, equities analysts plainly believe CareCloud is more favorable than Xunlei. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score CareCloud 0 Sell rating(s) 2 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.33 Xunlei 0 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00

Which has preferable earnings & valuation, CCLD or XNET?

Xunlei has higher revenue and earnings than CareCloud. Xunlei is trading at a lower price-to-earnings ratio than CareCloud, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio CareCloud $120.50M 0.83 $10.80M $0.11 21.50 Xunlei $462.41M 0.82 $1.05B $16.43 0.37

Is CCLD or XNET more profitable?

Xunlei has a net margin of 227.29% compared to CareCloud's net margin of 7.87%. CareCloud's return on equity of 24.05% beat Xunlei's return on equity. Company Net Margins Return on Equity Return on Assets CareCloud 7.87% 24.05% 16.38% Xunlei 227.29% 1.41% 1.17%

Does the media refer more to CCLD or XNET?

In the previous week, Xunlei had 4 more articles in the media than CareCloud. MarketBeat recorded 7 mentions for Xunlei and 3 mentions for CareCloud. Xunlei's average media sentiment score of 0.61 beat CareCloud's score of 0.47 indicating that Xunlei is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment CareCloud 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Xunlei 1 Very Positive mention(s) 1 Positive mention(s) 2 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive

Do analysts rate MIXT or CCLD?

CareCloud has a consensus target price of $3.25, suggesting a potential upside of 37.42%. Given CareCloud's stronger consensus rating and higher probable upside, analysts plainly believe CareCloud is more favorable than MiX Telematics. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score MiX Telematics 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 CareCloud 0 Sell rating(s) 2 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.33

Is MIXT or CCLD more profitable?

CareCloud has a net margin of 7.87% compared to MiX Telematics' net margin of 3.72%. CareCloud's return on equity of 24.05% beat MiX Telematics' return on equity. Company Net Margins Return on Equity Return on Assets MiX Telematics 3.72% 8.45% 5.11% CareCloud 7.87% 24.05% 16.38%

Do analysts recommend ECX or CCLD?

CareCloud has a consensus price target of $3.25, indicating a potential upside of 37.42%. Given CareCloud's stronger consensus rating and higher probable upside, analysts clearly believe CareCloud is more favorable than ECARX. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score ECARX 1 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.50 CareCloud 0 Sell rating(s) 2 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.33

Which has higher valuation and earnings, ECX or CCLD?

CareCloud has lower revenue, but higher earnings than ECARX. ECARX is trading at a lower price-to-earnings ratio than CareCloud, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio ECARX $847.90M 0.50 -$66.04M -$0.15 N/A CareCloud $120.50M 0.83 $10.80M $0.11 21.50

Is ECX or CCLD more profitable?

CareCloud has a net margin of 7.87% compared to ECARX's net margin of -6.23%. CareCloud's return on equity of 24.05% beat ECARX's return on equity. Company Net Margins Return on Equity Return on Assets ECARX -6.23% N/A -8.48% CareCloud 7.87% 24.05% 16.38%

Does the media prefer ECX or CCLD?

In the previous week, ECARX and ECARX both had 3 articles in the media. CareCloud's average media sentiment score of 0.47 beat ECARX's score of 0.44 indicating that CareCloud is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment ECARX 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral CareCloud 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

CareCloud (CCLD) Competitors

$2.37 +0.05 (+1.94%)

As of 12:58 PM Eastern

Compare

CCLD vs. XPER, BLND, XNET, MIXT, and ECX

Should you buy CareCloud stock or one of its competitors? MarketBeat compares CareCloud with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with CareCloud include Xperi (XPER), Blend Labs (BLND), Xunlei (XNET), MiX Telematics (MIXT), and ECARX (ECX). These companies are all part of the "computer software" industry.

How does CareCloud compare to Xperi?

CareCloud (NASDAQ:CCLD) and Xperi (NYSE:XPER) are both small-cap computer software companies, but which is the superior investment? We will contrast the two companies based on the strength of their risk, earnings, valuation, media sentiment, analyst recommendations, institutional ownership, profitability and dividends.

CareCloud has a net margin of 7.87% compared to Xperi's net margin of -10.22%. CareCloud's return on equity of 24.05% beat Xperi's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
CareCloud	7.87%	24.05%	16.38%
Xperi	-10.22%	1.09%	0.73%

CareCloud has a beta of 1.6, indicating that its share price is 60% more volatile than the broader market. Comparatively, Xperi has a beta of 1.37, indicating that its share price is 37% more volatile than the broader market.

CareCloud has higher earnings, but lower revenue than Xperi. Xperi is trading at a lower price-to-earnings ratio than CareCloud, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
CareCloud	$120.50M	0.83	$10.80M	$0.11	21.50
Xperi	$448.11M	0.84	-$56.34M	-$0.99	N/A

CareCloud presently has a consensus price target of $3.25, suggesting a potential upside of 37.42%. Xperi has a consensus price target of $11.00, suggesting a potential upside of 40.34%. Given Xperi's higher possible upside, analysts clearly believe Xperi is more favorable than CareCloud.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
CareCloud	0 Sell rating(s)	2 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.33
Xperi	1 Sell rating(s)	1 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.25

10.2% of CareCloud shares are held by institutional investors. Comparatively, 94.3% of Xperi shares are held by institutional investors. 14.8% of CareCloud shares are held by company insiders. Comparatively, 3.2% of Xperi shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

In the previous week, CareCloud had 3 more articles in the media than Xperi. MarketBeat recorded 3 mentions for CareCloud and 0 mentions for Xperi. Xperi's average media sentiment score of 1.00 beat CareCloud's score of 0.47 indicating that Xperi is being referred to more favorably in the news media.

Company	Overall Sentiment
CareCloud	Neutral
Xperi	Positive

Summary

CareCloud beats Xperi on 10 of the 16 factors compared between the two stocks.

How does CareCloud compare to Blend Labs?

CareCloud (NASDAQ:CCLD) and Blend Labs (NYSE:BLND) are both small-cap computer software companies, but which is the superior business? We will compare the two businesses based on the strength of their dividends, earnings, profitability, valuation, risk, media sentiment, analyst recommendations and institutional ownership.

CareCloud has higher earnings, but lower revenue than Blend Labs. Blend Labs is trading at a lower price-to-earnings ratio than CareCloud, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
CareCloud	$120.50M	0.83	$10.80M	$0.11	21.50
Blend Labs	$123.51M	3.56	-$6.80M	-$0.10	N/A

CareCloud currently has a consensus price target of $3.25, indicating a potential upside of 37.42%. Blend Labs has a consensus price target of $3.32, indicating a potential upside of 82.74%. Given Blend Labs' stronger consensus rating and higher probable upside, analysts clearly believe Blend Labs is more favorable than CareCloud.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
CareCloud	0 Sell rating(s)	2 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.33
Blend Labs	1 Sell rating(s)	2 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.43

In the previous week, CareCloud and CareCloud both had 3 articles in the media. CareCloud's average media sentiment score of 0.47 beat Blend Labs' score of -0.33 indicating that CareCloud is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
CareCloud	0 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Blend Labs	0 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

CareCloud has a beta of 1.6, meaning that its share price is 60% more volatile than the broader market. Comparatively, Blend Labs has a beta of 1.03, meaning that its share price is 3% more volatile than the broader market.

CareCloud has a net margin of 7.87% compared to Blend Labs' net margin of -3.72%. CareCloud's return on equity of 24.05% beat Blend Labs' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
CareCloud	7.87%	24.05%	16.38%
Blend Labs	-3.72%	N/A	-1.63%

10.2% of CareCloud shares are owned by institutional investors. Comparatively, 52.6% of Blend Labs shares are owned by institutional investors. 14.8% of CareCloud shares are owned by company insiders. Comparatively, 40.3% of Blend Labs shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

Summary

CareCloud beats Blend Labs on 8 of the 15 factors compared between the two stocks.

How does CareCloud compare to Xunlei?

CareCloud (NASDAQ:CCLD) and Xunlei (NASDAQ:XNET) are both small-cap computer software companies, but which is the superior business? We will compare the two businesses based on the strength of their institutional ownership, dividends, media sentiment, valuation, analyst recommendations, profitability, earnings and risk.

Xunlei has a net margin of 227.29% compared to CareCloud's net margin of 7.87%. CareCloud's return on equity of 24.05% beat Xunlei's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
CareCloud	7.87%	24.05%	16.38%
Xunlei	227.29%	1.41%	1.17%

CareCloud has a beta of 1.6, suggesting that its share price is 60% more volatile than the broader market. Comparatively, Xunlei has a beta of 1.13, suggesting that its share price is 13% more volatile than the broader market.

CareCloud currently has a consensus price target of $3.25, indicating a potential upside of 37.42%. Given CareCloud's stronger consensus rating and higher possible upside, equities analysts plainly believe CareCloud is more favorable than Xunlei.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
CareCloud	0 Sell rating(s)	2 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.33
Xunlei	0 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	2.00

In the previous week, Xunlei had 4 more articles in the media than CareCloud. MarketBeat recorded 7 mentions for Xunlei and 3 mentions for CareCloud. Xunlei's average media sentiment score of 0.61 beat CareCloud's score of 0.47 indicating that Xunlei is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
CareCloud	0 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Xunlei	1 Very Positive mention(s)	1 Positive mention(s)	2 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive

10.2% of CareCloud shares are held by institutional investors. Comparatively, 5.1% of Xunlei shares are held by institutional investors. 14.8% of CareCloud shares are held by insiders. Comparatively, 21.7% of Xunlei shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

Xunlei has higher revenue and earnings than CareCloud. Xunlei is trading at a lower price-to-earnings ratio than CareCloud, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
CareCloud	$120.50M	0.83	$10.80M	$0.11	21.50
Xunlei	$462.41M	0.82	$1.05B	$16.43	0.37

Summary

CareCloud beats Xunlei on 9 of the 16 factors compared between the two stocks.

How does CareCloud compare to MiX Telematics?

MiX Telematics (NYSE:MIXT) and CareCloud (NASDAQ:CCLD) are both small-cap computer software companies, but which is the better business? We will contrast the two businesses based on the strength of their analyst recommendations, risk, valuation, profitability, earnings, institutional ownership, dividends and media sentiment.

MiX Telematics has a beta of 1.15, meaning that its stock price is 15% more volatile than the broader market. Comparatively, CareCloud has a beta of 1.6, meaning that its stock price is 60% more volatile than the broader market.

In the previous week, CareCloud had 3 more articles in the media than MiX Telematics. MarketBeat recorded 3 mentions for CareCloud and 0 mentions for MiX Telematics. CareCloud's average media sentiment score of 0.47 beat MiX Telematics' score of 0.00 indicating that CareCloud is being referred to more favorably in the news media.

Company	Overall Sentiment
MiX Telematics	Neutral
CareCloud	Neutral

45.7% of MiX Telematics shares are owned by institutional investors. Comparatively, 10.2% of CareCloud shares are owned by institutional investors. 12.4% of MiX Telematics shares are owned by company insiders. Comparatively, 14.8% of CareCloud shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

CareCloud has a consensus target price of $3.25, suggesting a potential upside of 37.42%. Given CareCloud's stronger consensus rating and higher probable upside, analysts plainly believe CareCloud is more favorable than MiX Telematics.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
MiX Telematics	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00
CareCloud	0 Sell rating(s)	2 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.33

CareCloud has lower revenue, but higher earnings than MiX Telematics. CareCloud is trading at a lower price-to-earnings ratio than MiX Telematics, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
MiX Telematics	$150.06M	2.36	$4.52M	$0.25	58.20
CareCloud	$120.50M	0.83	$10.80M	$0.11	21.50

CareCloud has a net margin of 7.87% compared to MiX Telematics' net margin of 3.72%. CareCloud's return on equity of 24.05% beat MiX Telematics' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
MiX Telematics	3.72%	8.45%	5.11%
CareCloud	7.87%	24.05%	16.38%

Summary

CareCloud beats MiX Telematics on 11 of the 16 factors compared between the two stocks.

How does CareCloud compare to ECARX?

ECARX (NASDAQ:ECX) and CareCloud (NASDAQ:CCLD) are both small-cap computer software companies, but which is the superior stock? We will compare the two businesses based on the strength of their analyst recommendations, profitability, institutional ownership, media sentiment, dividends, earnings, valuation and risk.

In the previous week, ECARX and ECARX both had 3 articles in the media. CareCloud's average media sentiment score of 0.47 beat ECARX's score of 0.44 indicating that CareCloud is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
ECARX	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
CareCloud	0 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

CareCloud has a consensus price target of $3.25, indicating a potential upside of 37.42%. Given CareCloud's stronger consensus rating and higher probable upside, analysts clearly believe CareCloud is more favorable than ECARX.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
ECARX	1 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.50
CareCloud	0 Sell rating(s)	2 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.33

CareCloud has lower revenue, but higher earnings than ECARX. ECARX is trading at a lower price-to-earnings ratio than CareCloud, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
ECARX	$847.90M	0.50	-$66.04M	-$0.15	N/A
CareCloud	$120.50M	0.83	$10.80M	$0.11	21.50

ECARX has a beta of 0.98, meaning that its stock price is 2% less volatile than the broader market. Comparatively, CareCloud has a beta of 1.6, meaning that its stock price is 60% more volatile than the broader market.

10.2% of CareCloud shares are owned by institutional investors. 20.0% of ECARX shares are owned by company insiders. Comparatively, 14.8% of CareCloud shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

CareCloud has a net margin of 7.87% compared to ECARX's net margin of -6.23%. CareCloud's return on equity of 24.05% beat ECARX's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
ECARX	-6.23%	N/A	-8.48%
CareCloud	7.87%	24.05%	16.38%

Summary

CareCloud beats ECARX on 13 of the 15 factors compared between the two stocks.

Get CareCloud News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding CCLD and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

CCLD vs. The Competition

Export

Metric	CareCloud	MEDICAL INFO SYS Industry	Medical Sector	NASDAQ Exchange
Market Cap	$100.49M	$1.55B	$6.42B	$12.60B
Dividend Yield	N/A	N/A	2.75%	5.26%
P/E Ratio	21.50	78.28	21.28	26.32
Price / Sales	0.83	6.68	558.91	114.49
Price / Cash	3.27	22.51	43.49	56.90
Price / Book	1.73	7.48	10.60	7.34
Net Income	$10.80M	-$54.76M	$3.56B	$337.06M
7 Day Performance	3.73%	1.04%	3.21%	3.67%
1 Month Performance	-20.37%	10.87%	6.51%	7.41%
1 Year Performance	11.56%	-0.10%	36.74%	37.93%

CareCloud Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
CCLD CareCloud	3.6672 of 5 stars	$2.37 +1.9%	$3.25 +37.4%	+13.2%	$100.49M	$120.50M	21.50	3,650
XPER Xperi	4.0404 of 5 stars	$7.58 -0.4%	$11.00 +45.1%	N/A	$366.03M	$448.11M	N/A	1,460
BLND Blend Labs	3.6914 of 5 stars	$1.49 -6.0%	$3.32 +123.3%	-51.2%	$359.55M	$123.51M	N/A	1,690	Gap Up
XNET Xunlei	1.8161 of 5 stars	$5.69 -2.6%	N/A	-9.7%	$357.62M	$462.41M	0.35	1,306	News Coverage Positive News
MIXT MiX Telematics	N/A	$14.55 flat	N/A	N/A	$353.75M	$150.06M	58.20	1,080

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:CCLD) was last updated on 5/29/2026 by MarketBeat.com Staff.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

CareCloud (CCLD) Competitors